Health Condition 1: - Health Condition 2: O- Medical and Surgical
Conditions
Interventions
Intervention1: Dexmedetomidine: 3.4 ml of 0.5% ropivacaine (heavy) and 10 mcg of dexmedetomidine.
Control Intervention1: Clonidine: 3.4ml of 0.5% ropivacaine(heavy) and 30mcg of clonidine
Sponsors
Datta Meghe Institute of Higher Education and Research
Eligibility
Inclusion criteria
Inclusion criteria: 1.) Adult patients between the ages of 18 and 60 years, 2.) Patients scheduled for elective infra-umbilical surgeries, 3.) American Society of Anesthesiologists (ASA) physical status I or II, 4.) Surgery duration ranging between one and three hours.
Exclusion criteria
Exclusion criteria: 1.) Allergic reactions to any of the research drugs. 2.) Recognized contraindications to spinal anesthesia, 3.) Significant cardiovascular disease or a history of cardiac arrhythmias, 4.) Pregnant females, 5.) Coagulopathy or hemorrhagic conditions, 6.) Surgery duration less than one hour or more than three hours 7.) Incapacity to give informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Onset of sensory and motor blockade The level of sedation Hemodynamic parameters Timepoint: 24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| NilTimepoint: Nil | — |
Countries
India
Contacts
Public ContactDr Jayashree Sen
Datta Meghe Institute Of Higher Education And Research
Outcome results
None listed